Diabetes affects approximately 463 million people worldwide (International Diabetes Federation, 2020). Diabetes frequently presents together with other comorbidities and can result in life-threatening complications. Over the past several decades, the number of adults diagnosed with diabetes in the U.S. has increased drastically. In 2018, 34.2 million Americans had diabetes, and this number increases by approximately 1.5 million every year (Centers for Disease Control and Prevention [CDC], 2020). Unfortunately, according to the World Health Organization (WHO), rising numbers are now seen more in low to middle-income countries (WHO, 2021).
Diabetes affects approximately 463 million people worldwide (International Diabetes Federation, 2020). Diabetes frequently presents together with other comorbidities and can result in life-threatening complications. Over the past several decades, the number of adults diagnosed with diabetes in the U.S. has increased drastically. In 2018, 34.2 million Americans had diabetes, and this number increases by approximately 1.5 million every year (Centers for Disease Control and Prevention [CDC], 2020). Unfortunately, according to the World Health Organization (WHO), rising numbers are now seen more in low to middle-income countries (WHO, 2021).
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Florida Board of Pharmacy (CEBroker Provider #50-290)
This program has been pre-approved by The Commission for Case Manager Certification to provide 1.0000 hours of continuing education credit to CCM® board certified case managers.
Outline:
Non-Pharmacological Management Strategies for Diabetes
Section 3: Pharmacological Management Strategies: Oral Antidiabetic Drugs
Alpha-Glucosidase Inhibitors (AGIs)
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors
Section 4: Injectable and Inhaled Management Strategies
Glucagon-Like Peptide-1 (GLP-1) Analogs
GLP-1 Analog and Insulin Combinations
Tracy Garrison, BSN, RN is a SME Writer at Relias. Her primary writing responsibilities are in the Acute Care vertical. Mrs. Garrison has a Bachelor of Science Degree in Nursing from Barton College. She has over 8 years of experience working as a Clinical Nurse in a large community hospital in North Carolina. Her background is in Postpartum care in addition to Cardiovascular Care. In addition to Women's Health, she is enthusiastic about preventative care, holistic medicine, and physical and rehabilitation medicine.
Disclosure: Tracy Garrison, BSN,RN has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.